Du, Yunlan <br/><br/>
Multiple molecular pathways are involved in the neuroprotection of GDNF against proteasome inhibitor induced dopamine neuron degeneration in vivo.  [electronic resource] 

 -  Experimental biology and medicine (Maywood, N.J.)  Jul 2008 
 - 881-90 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1535-3702 
<br/><br/><label>Standard No.: </label>10.3181/0712-RM-329  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acetylcysteine--adverse effects<br/>Animals<br/>Cysteine Proteinase Inhibitors--adverse effects<br/>Disease Models, Animal<br/>Dopamine--metabolism<br/>Glial Cell Line-Derived Neurotrophic Factor--therapeutic use<br/>JNK Mitogen-Activated Protein Kinases--metabolism<br/>Male<br/>Mice<br/>Mice, Inbred C57BL<br/>Mitogen-Activated Protein Kinase Kinases--metabolism<br/>Nerve Degeneration--metabolism<br/>Parkinson Disease--etiology<br/>Phosphatidylinositol 3-Kinases--metabolism<br/>Proteasome Inhibitors<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>Random Allocation<br/>Signal Transduction--drug effects<br/>Substantia Nigra--drug effects<br/>p38 Mitogen-Activated Protein Kinases--metabolism